This was a multicenter study carried out in India to study the adverse and systemic effects of the indigenously developed Covishield vaccine. Objectives: Nationwide COVID-19 vaccination was initiated ...

Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, branded Covishield, can cause rare side effects including blood clots and low platelet count. Covishield was developed ...

BENGALURU, Nov 26 (Reuters) - India restarted exports of COVID-19 shots to the global vaccine-sharing network COVAX on Friday for the first time since April, and producer Serum Institute of India (SII ...

The World Health Organization (WHO) said it has identified counterfeit versions of India's primary Covid vaccine, Covishield. The doses were seized by authorities in India and Africa between July and ...

The first frontline health workers being inoculated with Covishield last week in Kathmandu from the 1 million doses of the AstraZeneca vaccine donated by India. Photo: MONIKA DEUPALA The Ministry of ...

BENGALURU, Dec 31 (Reuters) - Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company's chief ...